Cited by 661Cancer Genomics and DiagnosticsCancer Cells and MetastasisEvolution and Genetic Dynamics

Metastasis as an evolutionary process

Turajlic, Samra, Swanton, Charles·2016·Science

Abstract

Therapeutic advances in oncology have not fully translated to the treatment of metastatic disease, which remains largely incurable. Metastatic subclones can emerge both early and late in the life of the primary tumor. A better understanding of the genetic evolution of metastatic disease has the potential to reveal differences in the therapeutic vulnerabilities of primary and metastatic tumors, shed light on the temporal patterns of and routes to metastatic colonization, and provide insight into the biology of the metastatic process. Here we review recent comparative studies of primary and metastatic tumors, including data suggesting that macroevolutionary shifts (the onset of chromosomal instability) contribute to the evolution of metastatic disease. We also discuss the practical challenges associated with these studies and how they might be overcome.

Integrity signals

Registry

Crossref · 10.1126/science.aaf2784

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Turajlic, S., & Swanton, C.
Affiliations
The Francis Crick Institute (GB)
Corresponding author
Swanton, Charles
Venue
Science
Published
2016-04-08
Volume
352
Issue
6282
Pages
169-175
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2315243978
Cited by
661
References
5
Citations by year
2026: 45 · 2025: 61 · 2024: 75 · 2023: 62 · 2022: 75 · 2021: 72 · 2020: 78 · 2019: 56 · 2018: 57 · 2017: 56 · 2016: 23 · 2015: 1
FWCI
5.87
Type
journal article
Language
en
Open access
closed
Locations
  • Science (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Cancer Research UK (C50947/A18176)
  • National Institute for Health Research (NIHR)
  • Rosetrees Trust
  • NovoNordisk Foundation (16584)
  • European Union 7th Framework Programme
  • Prostate Cancer Foundation
  • Breast Cancer Research Foundation
  • European Research Council
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
Keywords
metastasis, tumor evolution, primary tumor, chromosomal instability, therapeutic vulnerabilities, metastatic colonization, tumor heterogeneity
MeSH terms
Clone Cells, Humans, Neoplasm Metastasis, Neoplasms, Phylogeny, Genetic Variation, Evolution, Molecular

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review